Schwartz Investment Counsel’s Quest Diagnostics DGX Stock Holding History

Schwartz Investment Counsel’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.3M	Hold	95,900	–	–	0.67%	45
2026 Q1	$18.8M	Hold	95,900	–	–	0.67%	51
2025 Q4	$16.6M	Hold	95,900	–	–	0.58%	57
2025 Q3	$18.3M	Hold	95,900	–	–	0.61%	56
2025 Q2	$17.2M	Hold	95,900	–	–	0.57%	56
2025 Q1	$16.2M	Hold	95,900	–	–	0.56%	51
2024 Q4	$14.5M	Sell	95,900 -166	-0.2%	-$25.8K	0.52%	51
2024 Q3	$14.9M	Hold	96,066	–	–	0.53%	55
2024 Q2	$13.1M	Hold	96,066	–	–	0.49%	58
2024 Q1	$12.8M	Hold	96,066	–	–	0.47%	58
2023 Q4	$13.2M	Hold	96,066	–	–	0.52%	56
2023 Q3	$11.7M	Hold	96,066	–	–	0.5%	59
2023 Q2	$13.5M	Hold	96,066	–	–	0.57%	51
2023 Q1	$13.6M	Hold	96,066	–	–	0.59%	48
2022 Q4	$15M	Hold	96,066	–	–	0.68%	46
2022 Q3	$11.8M	Sell	96,066 -166	-0.2%	-$21.9K	0.61%	47
2022 Q2	$12.8M	Hold	96,232	–	–	0.62%	45
2022 Q1	$13.2M	Sell	96,232 -16,300	-14%	-$2.27M	0.55%	46
2021 Q4	$19.5M	Sell	112,532 -70,000	-38%	-$10.7M	0.76%	44
2021 Q3	$26.5M	Sell	182,532 -40,000	-18%	-$5.85M	1.09%	34
2021 Q2	$29.4M	Hold	222,532	–	–	1.18%	31
2021 Q1	$28.6M	Hold	222,532	–	–	1.24%	33
2020 Q4	$26.5M	Hold	222,532	–	–	1.2%	34
2020 Q3	$25.5M	Hold	222,532	–	–	1.29%	33
2020 Q2	$25.4M	Buy	222,532 +33,132	+17%	+$3.51M	1.38%	32
2020 Q1	$15.2M	Buy	+189,400	New	+$19.6M	1.01%	41

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Schwartz Investment Counsel's DGX Position: Q2 2026 in Review

Schwartz Investment Counsel held its Quest Diagnostics (DGX) position steady in Q2 2026 at 95,900 shares worth $20.3M. The position accounts for 0.67% of the portfolio, ranked #45.

Schwartz Investment Counsel first reported a position in DGX in Q1 2020 and has held it in 26 quarters since. The position peaked at $29.4M in Q2 2021. 1,112 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Schwartz Investment Counsel held 95,900 shares of Quest Diagnostics worth $20.3M as of Q2 2026.
Schwartz Investment Counsel left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.67% of Schwartz Investment Counsel's portfolio in Q2 2026, its #45 holding.
Schwartz Investment Counsel first reported a position in Quest Diagnostics in Q1 2020 and has held it in 26 quarters since.
Schwartz Investment Counsel's Quest Diagnostics position peaked at $29.4M in Q2 2021.
1,112 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Schwartz Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.